Russell Investments Group, Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in FULC

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$381,366

-$225,764 QoQ

Shares Held

104,199

+31.6% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#60

of 154 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. FULC ranks #159 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$381,366	104,199	+31.6%	Shares	Defined	2026-08-06
2026-03-31	$607,130	79,157	+2114.8%	Shares	Defined	2026-05-08
2025-12-31	$40,421	3,574	-74.0%	Shares	Defined	2026-02-17
2025-09-30	$126,324	13,731	+47.5%	Shares	Defined	2025-11-13
2025-06-30	$64,038	9,308	+4209.3%	Shares	Defined	2025-08-13
2025-03-31	$622	216	-31.2%	Shares	Defined	2025-05-13
2024-12-31	$1,475	314	+568.1%	Shares	Defined	2025-02-13
2024-09-30	$167	47	-94.9%	Shares	Defined	2024-11-13
2023-03-31	$2,636	925	-28.8%	Shares	Defined	2023-05-09
2020-12-31	$15,223	1,300	0.0%	Shares	Defined	2021-02-08
2020-09-30	$10,309	1,300	0.0%	Shares	Defined	2020-11-09
2020-06-30	$23,777	1,300	—	Shares	Defined	2020-08-05
No filing history on record for this holder in this stock.